Study: Cancer-related genetic testing is rare for women on Medicare

August 20, 2018 6:28 pm

By Health Day News

Testing for gene mutations linked to breast and ovarian cancer is rare among some Medicare patients who have the cancers and qualify for such tests, a new study finds.

Researchers analyzed data from 12 southeastern states … Read more

Genetic Screening Can Inform Women of Their Breast and Ovarian Cancer Risks

July 6, 2018 7:21 pm

One of the most unsettling aspects of cancer is the unknown.

There is the unknown of what is in store for you if you receive a diagnosis of cancer. But on a larger scale, we all

Read more

Busting Myths Surrounding Cancer and Genetic Testing

April 18, 2018 12:02 am

While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.

This is especially true in families with … Read more

U.S. To Cover Advanced Genomic Testing For Medicare Cancer Patients

March 19, 2018 7:17 pm

The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.

The Centers for Medicare & Medicaid … Read more

FDA Approves 23andMe Cancer Test For BRCA Genes

March 12, 2018 8:33 pm

The home DNA testing company 23andMe has received approval from the US Food and Drug Administration (FDA) to test for three genetic mutations in two genes that you have probably heard of if you know who Angelina Jolie is, BRCA1 … Read more

Ovarian Cancer: How Your Father’s Genes Can Affect Your Risk

February 19, 2018 12:01 am

Scientists studying ovarian cancer have revealed a new genetic mutation that increases a woman’s risk of ovarian cancer — and it can be passed to her by her father.

Recently, Medical News Today covered a study that looked into whether … Read more

Screening Beyond Those With Cancer History May Be More Effective

February 12, 2018 10:32 pm

As genetic testing becomes more accessible with advanced technology and decreased costs, population-based testing for breast and ovarian cancer may be more cost effective in the long run, according to study results published in Journal of the National Cancer InstituteRead more

Should All Women Be Tested for Breast, Ovarian Cancer Gene Mutations?

January 31, 2018 7:27 pm

Evidence is growing that all women age 30 and older should be tested for the inherited gene mutations that can cause breast and ovarian cancer, according to British researchers.

“We could prevent thousands more ovarian and breast cancers through a … Read more

7 Key Cancer Trends For 2018

January 3, 2018 6:48 pm

By: Elaine Schattner

I expect progress. Here’s my list of major trends and issues that will affect the lives of cancer patients in 2018:

1. Less chemotherapy

recent report finds that among patients with the most common form of … Read more

Health Matters: Testing Your Genes for Cancer

December 12, 2017 12:21 am

Whether you’ve already been diagnosed, or you want to know your risk, health experts can test your DNA to determine your chances of developing cancer.

“The testing itself determines whether or not they have inherited this broken gene that could … Read more

More Expansive Genetic Testing Needed in Ovarian Cancer

October 5, 2017 3:30 pm

More research is needed on the other genetic mutations, besides BRCA, that patients with ovarian cancer harbor so that they can be used to help plan treatments.

However, there is hope for such research to emerge. Ophira Ginsburg, M.D., director … Read more

The Role of Genetic Testing in Ovarian Cancer

August 8, 2017 2:59 am

Pathologists and oncologists work closely together to treat patients with cancer, and will continue to do so as more individualized treatments become popular. In ovarian cancer, tumors evolve over time, making this relationship between members of the treatment team even … Read more

Gene Testing Could Help Predict Ovarian Cancer Patients’ Sensitivity

January 2, 2017 7:55 pm

Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals.

Scientists found that defects in a gene called ARID1A caused … Read more

The Unbearably Slow Adoption of Genetic Cancer Tests

July 12, 2016 5:29 pm

Over the past 20 years, Nazneen Rahman has identified a steady stream of genes that influence the risk of breast, ovarian, and childhood cancers—work that has earned her scientific, popular, and even royal acclaim. But her latest accomplishment, and one … Read more